Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tetrabenazine 25mg tablets
0409030C0AAAAAA
|
Tetrabenazine | Tetrabenazine | Central Nervous System | 8,984 |
|
Tetrabenazine 25mg/5ml oral suspension
0409030C0AAARAR
|
Tetrabenazine | Tetrabenazine | Central Nervous System | 106 |
|
Tetrabenazine 12.5mg/5ml oral suspension
0409030C0AAASAS
|
Tetrabenazine | Tetrabenazine | Central Nervous System | 75 |
|
Tetrabenazine 10mg/5ml oral suspension
0409030C0AAAMAM
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 12.5mg tablets
0409030C0AAAQAQ
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 2.5mg/5ml oral suspension
0409030C0AAAPAP
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 31.25mg/5ml oral suspension
0409030C0AAALAL
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 50mg/5ml oral suspension
0409030C0AAAGAG
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 5mg/5ml oral suspension
0409030C0AAAJAJ
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 6.25mg/5ml oral suspension
0409030C0AAANAN
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 62.5mg/5ml oral suspension
0409030C0AAAKAK
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
|
Tetrabenazine 75mg/5ml oral suspension
0409030C0AAAHAH
|
Tetrabenazine | Tetrabenazine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.